To meet the needs of a growing laboratory, making the right choice for manufacturing vendor, instrumentation platform and testing menu can be complicated. Depending upon a multitude of variables such as the size of the laboratory, staffing configurations and client needs, decisions can take a laboratory manager in a variety of directions.

The consideration should be the versatility of the platform. After taking these variables into consideration, there are many cost reduction strategies that can be used to make the most of a laboratory’s purchasing power, knowing the pricing of a competitor will give the laboratory an advantage when negotiating an instrument purchase. Also, when negotiating reagent pricing, know your numbers. It is definitely true that consolidation of testing to one vendor platform can have a financial reward. Automation systems, LIS interfaces, reagent shipping and other ancillary supports can be shared. Tech time is optimized by learning one platform and training, competency can be uniformly handled. Service agreements, reagent pricing contracts and cost per reportable pricing can also be negotiated in an instrument purchase contract as a cost control measure.

Provide expertise on Purchase of major players , Qiagen, Roche, Abott, Siemens Healthineers,  Illumina, PacBio, MGI.Tech, Eppendorf,  BioRad, Thermofisher , Agilent, technologies etc,